
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patient-derived xenografts and organoids model therapy response in prostate cancer
Sofia Karkampouna, Federico La Manna, Andrej Benjak, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 119
Sofia Karkampouna, Federico La Manna, Andrej Benjak, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 119
Showing 1-25 of 119 citing articles:
NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression
Hao Zhang, Xiangyu Zhai, Yanfeng Liu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 53
Hao Zhang, Xiangyu Zhai, Yanfeng Liu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 53
Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
Elena M. Tosca, Davide Ronchi, Daniele Facciolo, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1058-1058
Open Access | Times Cited: 50
Elena M. Tosca, Davide Ronchi, Daniele Facciolo, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1058-1058
Open Access | Times Cited: 50
Bladder cancer organoids as a functional system to model different disease stages and therapy response
Martina Minoli, Thomas Cantore, Daniel Hanhart, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Martina Minoli, Thomas Cantore, Daniel Hanhart, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Organoid cultures for cancer modeling
Helen H.N. Yan, April Chan, Frank Pui-Ling Lai, et al.
Cell stem cell (2023) Vol. 30, Iss. 7, pp. 917-937
Open Access | Times Cited: 47
Helen H.N. Yan, April Chan, Frank Pui-Ling Lai, et al.
Cell stem cell (2023) Vol. 30, Iss. 7, pp. 917-937
Open Access | Times Cited: 47
Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy
Jingjing Qu, Farhin Shaheed Kalyani, Li Liu, et al.
Cancer Communications (2021) Vol. 41, Iss. 12, pp. 1331-1353
Open Access | Times Cited: 101
Jingjing Qu, Farhin Shaheed Kalyani, Li Liu, et al.
Cancer Communications (2021) Vol. 41, Iss. 12, pp. 1331-1353
Open Access | Times Cited: 101
Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
Andrew M. K. Law, Laura Rodríguez de la Fuente, Thomas J. Grundy, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 69
Andrew M. K. Law, Laura Rodríguez de la Fuente, Thomas J. Grundy, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 69
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression
Marco Bolis, Daniela Bossi, Arianna Vallerga, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Marco Bolis, Daniela Bossi, Arianna Vallerga, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Prostate cancer patient‐derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens
Raphaëlle Servant, Michele Garioni, Tatjana Vlajnic, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 5, pp. 543-555
Open Access | Times Cited: 58
Raphaëlle Servant, Michele Garioni, Tatjana Vlajnic, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 5, pp. 543-555
Open Access | Times Cited: 58
Dissecting metastasis using preclinical models and methods
Jess D. Hebert, Joel W. Neal, Monte M. Winslow
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 391-407
Closed Access | Times Cited: 41
Jess D. Hebert, Joel W. Neal, Monte M. Winslow
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 391-407
Closed Access | Times Cited: 41
Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
Lucas Germain, Camille Lafront, Virginie Paquette, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 8, pp. 480-493
Closed Access | Times Cited: 24
Lucas Germain, Camille Lafront, Virginie Paquette, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 8, pp. 480-493
Closed Access | Times Cited: 24
Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Dongxi Xiang, Aina He, Rong Zhou, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3300-3316
Open Access | Times Cited: 16
Dongxi Xiang, Aina He, Rong Zhou, et al.
Theranostics (2024) Vol. 14, Iss. 8, pp. 3300-3316
Open Access | Times Cited: 16
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series
Nicolás Anselmino, Estefanía Labanca, Peter D.A. Shepherd, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2272-2285
Open Access | Times Cited: 11
Nicolás Anselmino, Estefanía Labanca, Peter D.A. Shepherd, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2272-2285
Open Access | Times Cited: 11
Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer
Gangyin Zhao, Gabriel Forn‐Cuní, Marvin Scheers, et al.
Cancer Letters (2024) Vol. 587, pp. 216657-216657
Open Access | Times Cited: 9
Gangyin Zhao, Gabriel Forn‐Cuní, Marvin Scheers, et al.
Cancer Letters (2024) Vol. 587, pp. 216657-216657
Open Access | Times Cited: 9
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
Gail P. Risbridger, Ashlee K. Clark, Laura H. Porter, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Gail P. Risbridger, Ashlee K. Clark, Laura H. Porter, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
Mirjam Kiener, Nuria Roldán, Carlos Machahua, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 47
Mirjam Kiener, Nuria Roldán, Carlos Machahua, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 47
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
Sahithi Pamarthy, Hatem E. Sabaawy
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Sahithi Pamarthy, Hatem E. Sabaawy
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Patient-Derived Organoids of Cholangiocarcinoma
Christopher Maier, Lei Zhu, Lahiri Kanth Nanduri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8675-8675
Open Access | Times Cited: 45
Christopher Maier, Lei Zhu, Lahiri Kanth Nanduri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8675-8675
Open Access | Times Cited: 45
Vascularized Tumor Spheroid-on-a-Chip Model Verifies Synergistic Vasoprotective and Chemotherapeutic Effects
Zhiwei Hu, Yuanxiong Cao, Edgar A. Galan, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 3, pp. 1215-1225
Closed Access | Times Cited: 38
Zhiwei Hu, Yuanxiong Cao, Edgar A. Galan, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 3, pp. 1215-1225
Closed Access | Times Cited: 38
Advances in 3D Bioprinting for Cancer Biology and Precision Medicine: From Matrix Design to Application
MoonSun Jung, Sarah Ghamrawi, Eric Y. Du, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 24
Open Access | Times Cited: 38
MoonSun Jung, Sarah Ghamrawi, Eric Y. Du, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 24
Open Access | Times Cited: 38
Deregulation of SPOP in Cancer
Hui Zhang, Xiaofeng Jin, Haojie Huang
Cancer Research (2022) Vol. 83, Iss. 4, pp. 489-499
Open Access | Times Cited: 29
Hui Zhang, Xiaofeng Jin, Haojie Huang
Cancer Research (2022) Vol. 83, Iss. 4, pp. 489-499
Open Access | Times Cited: 29
Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells
Ziruoyu Wang, Yanan Li, Wensi Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Ziruoyu Wang, Yanan Li, Wensi Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Cancer organoids: A platform in basic and translational research
Xin Ma, Qin Wang, Guozheng Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 614-632
Open Access | Times Cited: 20
Xin Ma, Qin Wang, Guozheng Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 614-632
Open Access | Times Cited: 20
Prostate organoids: emerging experimental tools for translational research
Michael L. Beshiri, Supreet Agarwal, Juan Juan Yin, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 19
Michael L. Beshiri, Supreet Agarwal, Juan Juan Yin, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 10
Open Access | Times Cited: 19
Organoids: opportunities and challenges of cancer therapy
Xianjie Jiang, Linda Oyang, Peng Qiu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 19
Xianjie Jiang, Linda Oyang, Peng Qiu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 19